Return on Investment in Discovery Chiral Separations
|
|
- Dorcas Ryan
- 6 years ago
- Views:
Transcription
1 Return on Investment in Discovery Chiral Separations Averica Discovery Services 260 Cedar Hill Street Marlborough MA
2 What Should I Spend? Understanding ROI There are entire business school courses on this subject, but there are four easier methods: 1. Changing Value Method 2. Negative Impact of Gantt Chart Slippage 3. Rough Calculation of Running Costs 4. Relative Costs of Alternatives These are fast and simple no complex value metrics or calculations. Each can be conceptually represented by scribbling on a cocktail napkin. Which method you use depends on both your goals and on your program s progress.
3 Nomination: Frequent R&D Choke Point Rapid assessment and decision-making keeps a program moving
4 De-Risking and Profiling: Supply is Critical Best Practice List for Pre-GLP Safety Assessment Average Phys. Chem. prop prediction 94% Genotox pilot (e.g. mini-ames) 87% Off-target assays (e.g. CEREP) 87% herg inhibition (e.g. auto patch clamp) 85% Reactive metabolite detection 85% 1-2 week pilot tox in rodent 82% Genotox prediction (e.g. DEREK) 79% General tox & ADME prediction (e.g. MCASE, TOPKAT) 74% Mouse micronucleus (gene tox) 72% Ames (normal Ames) 68% 3-4 day mini-tox in rodent 68% Safety pharmacology core battery 66% Safety pharmacology telemetry 62% 1-2 week pilot tox in large species 60% herg screening (e.g. Rb efflux) 57% Transporter binding/inhibition 57% Percentage of programs requiring specific assay prior to full development - Source: Drug Safety Executive Council (DSEC) survey of 20 Directors of safety assessment at major pharmaceutical companies, 2011
5 Changing Value Method Changing value = changing impact on cost/benefit of delays, successes, disruptions
6 Changing Value Method In hit-to-lead or lead optimization: How fast is the program moving impact of delay? Are there ancillary benefits: validation of mechanism? Better assay results? In candidate selection: How much material is needed to finalize lead selection? How many compounds are potential candidates? Can you source the active enantiomer in increasing amounts? What are the costs of a delay or quality problem? Averica has a >95% success rate with chiral separations
7 Gantt Chart Slippage Overall timeline tracks the critical path. If a non-cp task is delayed, the critical path can shift and the timeline increase In Discovery, assays are generally on the critical path and supply is not
8 Gantt Charts Discovery vs. Development Discovery Compound profiling determines timeline - supply should not slow things down Chromatography is the fastest source for chirally pure material Validate mechanism, improve assay signal/noise, and speed decision making Development Availability of supply keeps things progressing prior to development of a scaled synthesis Take advantage of scalable supply: Averica can deliver 10s-100s of grams in days
9 Calculating Program Run Costs Simple assumptions can lead to a fairly accurate calculation of running costs This method is useful in assessing cost of options according to their time cost or their consumption of additional resource
10 Cost Calculation: Common Conclusions Weekly Discovery program costs are in the tens of thousands of $, increasing as the program progresses Even if you shift chemists off the program, overhead costs continue to escalate No matter what your absolute costs, the DIY approach makes sense only when outsourcing = delays Averica s industry leading success rate and rapid turnaround can lower costs and shorten timelines
11 Decisions Based on Relative Costs Suppose you want 50 grams of 98% ee material for assays. Put alternatives into time and resource terms, and use the Program Run Cost Model. Then figure the chances of success: 1-6 weeks of chemist effort to develop an asymmetric synthesis (90% chance of success) 2-4 weeks of chemist effort to develop a diastereomeric crystallization (75% chance of success) 1-2 weeks to resolve material chromatographically (100% chance of success)
12 Relative Cost Scenarios Imagine a program exploring three chiral late stage leads. To nominate any one requires 200 grams for profiling and de-risking. Internal medicinal chemistry can make racemic at the 50 gram scale. Choices: 1. Develop an asymmetric process and transfer it to CRO. Have them make grams of each compound. 2. Beg, borrow or steal internal Process Chemistry resources. Have them do it. 3. Have medicinal chemist make 50 g at a time, and resolve it chromatographically. Choice 3 has limited chance of delay, and is less wasteful it s unlikely that 200 grams will be needed for all three compounds
13 Relative Cost Models Compare spending on the three choices over time Averica helps ensure steady supply as needed, when needed
14 Averica Discovery Services, Inc. A boutique CRO: Contract chemistry services, small molecule pharmaceutical sector, non-gmp focus Specialized separations technology to provide scalable supply for lead advancement, chiral compounds, reference standards, accurate assay results Accelerated Development: Assessing lead candidates at pre-nomination stage Massachusetts corporation established 2007 Newly expanded, 4400 ft 2 laboratories in Marlborough, MA Over 150 clients in pharma, agricultural chemicals, veterinary medicine, and flavor/fragrance industry
15 What You Get with Averica Averica has a >95% success rate with chiral and other difficult separations Scalable assay supply fast: 10s- 100s of grams in 3-5 days Key intermediate supply to 1 kg Method development can be scaled further for CTM production Preformulation services facilitate accelerated candidate nomination and development Stress degradation and HPLC method development for preliminary stability assessment
16 Detailed List of Services Purification High efficiency SFC purification, chiral separations Absolute configuration, Certificate of Analysis Labile or sensitive compounds Scalable supply: 5 mg to 1 kg LCMS, ELSD detection NMR, thermal analysis DEA Controlled substance license (all Schedules) Impurity Isolation Batch impurities isolated to 0.01% of bulk Stress degradation studies Full structure elucidation using 2D NMR and accurate mass MS/MS Reference standards Multiple components from one sample Consultation with project team and downstream CROs Pre-formulation Services Discovery phase-appropriate salt selection Phase-appropriate solid state work Preliminary stability HPLC method Kinetic and equilibrium solubility, pka, logp/logd
17 Contact Averica Averica Discovery Services 260 Cedar Hill Street Marlborough MA Jeffrey Kiplinger, President
Tips and Tricks for SFC Method Development
Tips and Tricks for SFC Method Development Jeffrey Kiplinger, Paul Lefebvre, Mickey Rego Averica Massachusetts, USA Waters User s Meeting, Prague CZ, December 2015 The Good Enough Concept Good enough requires
More informationSince 1988 High Force Research has worked with organizations operating in practically all end use sectors requiring chemical synthesis input, and
Since 1988 High Force Research has worked with organizations operating in practically all end use sectors requiring chemical synthesis input, and offers a range of services allied to new product development
More informationAnalytical & Solid State Services. June 2017
Analytical & Solid State Services June 2017 Analytical & Solid State Services Through our global network of laboratories, we serve clients with GMP and non-gmp requirements. FDA and EMEA registered. DEA
More informationYour Partner for Specialty Chemical Innovation & Technology
CORPORATE OVERVIEW Your Partner for Specialty Chemical Innovation & Technology CORPORATE OVERVIEW OUR COMPANY GROWTH MPD Chemicals is a US-based manufacturer of custom and specialty chemicals with over
More informationSARA Pharm Solutions
SARA Pharm Solutions Who we are? Sara Pharm Solutions European Innovative R&D-based Solid state pharmaceutical CRO 2 Company Background Incorporated in Bucharest, Romania Contract Research Organization
More informationChiroSolve Enantiomer preparation for discovery, development and manufacturing
ChiroSolve Enantiomer preparation for discovery, development and manufacturing Presenter: Dr. Niteen A. Vaidya CTO, ChiroSolve Inc. 2065 Martin Ave. suite 107, Santa Clara, CA 95050 Telephone: (408) 834-8597
More informationAMRI COMPOUND LIBRARY CONSORTIUM: A NOVEL WAY TO FILL YOUR DRUG PIPELINE
AMRI COMPOUD LIBRARY COSORTIUM: A OVEL WAY TO FILL YOUR DRUG PIPELIE Muralikrishna Valluri, PhD & Douglas B. Kitchen, PhD Summary The creation of high-quality, innovative small molecule leads is a continual
More informationFor Excellence in Organic Chemistry
Organix Inc. Your Contract Research and Custom Synthesis Company www.organixinc.com For Excellence in Organic Chemistry Organix Inc. A Contract Research and Custom Synthesis Company At the discovery end
More informationHandling Human Interpreted Analytical Data. Workflows for Pharmaceutical R&D. Presented by Peter Russell
Handling Human Interpreted Analytical Data Workflows for Pharmaceutical R&D Presented by Peter Russell 2011 Survey 88% of R&D organizations lack adequate systems to automatically collect data for reporting,
More informationCONTINUOUS FLOW CHEMISTRY (PROCESSING) FOR INTERMEDIATES AND APIs
CONTINUOUS FLOW CHEMISTRY (PROCESSING) FOR INTERMEDIATES AND APIs Sripathy Venkatraman, Section Head at AMRI Abstract Many contract manufacturing organizations (CMOs) offer continuous flow chemistry, but
More informationIntroduction CONTENTS
Managing Impurity Knowledge in a Process Chemistry Environment Ryan Sasaki and Graham A. McGibbon Advanced Chemistry Development, Inc. Toronto, ON, Canada www.acdlabs.com CONTENTS Introduction 1 Managing
More informationKalexsyn Overview Kalexsyn, Inc Campus Drive Kalamazoo, MI Phone: (269) Fax: (269)
Kalexsyn verview 2017 Kalexsyn, Inc. 4502 Campus Drive Kalamazoo, MI 49008 Phone: (269) 488-8488 Fax: (269) 488-8490 info@kalexsyn.com What we are Experienced medicinal chemists Conception and synthesis
More informationChromegaChiral TM Columns. The right choice for chiral purification
ChromegaChiral TM Columns The right choice for chiral purification Chiral Chromatography The Background... 01 Chiral Stationary Phases (CSP) and Chirality Comparison of Chiral and Achiral Molecules. (a)
More informationMy Career in the Pharmaceutical Industry
SCI Career Options Seminar My Career in the Pharmaceutical Industry Simon Yates, AstraZeneca University of Sheffield 27 th November 2013 1998-2002 - Degree MChem. Undergraduate at University of York Final
More informationPreformulation & Solid State Chemistry Services
Preformulation & Solid State Chemistry Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950 VxP Pharmaprovides manufacturing, testing
More informationHow to make the best out of Process R&D
How to make the best out of Process R&D What Exactly Does PR&D Do? $ The Role f Chemical Development To discover and develop robust, economic manufacturing processes for Candidate Drugs (CDs) To provide
More informationReaxys Medicinal Chemistry Fact Sheet
R&D SOLUTIONS FOR PHARMA & LIFE SCIENCES Reaxys Medicinal Chemistry Fact Sheet Essential data for lead identification and optimization Reaxys Medicinal Chemistry empowers early discovery in drug development
More informationChromegaChiral TM CSP Media and Columns
ChromegaChiral TM CSP Media and Columns p h a r m a c e u t i c a l e n v i r o n m e n t a l c h e m i c a l b i o c h e m i c a l s e p a r a t i o n & p u r i f i c a t i o n ES Industries 701 S. Route
More informationMeasuring enzyme (enantio)selectivity
Measuring enzyme (enantio)selectivity Types of selectivity - review stereoisomers Stereoselective synthesis (create) vs. resolutions (separate) Enantioselectivity & enantiomeric purity Ways to measure
More informationChromegaChiral TM CSP Media and Columns
ChromegaChiral TM CSP Media and Columns p h a r m a c e u t i c a l e n v i r o n m e n t a l c h e m i c a l b i o c h e m i c a l s e p a r a t i o n & p u r i f i c a t i o n ES Industries 701 S. Route
More informationImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry
Improving ADME Screening Productivity in Drug Discovery INTRODUCTION Improving the quality of the decisions made at the drug discovery stage can profoundly impact the efficiency of the drug discovery and
More informationCHAPTER 1 Role of Bioanalytical Methods in Drug Discovery and Development
UMMERY The need to develop new analytical methods for assurance of quality, safety and efficacy of drugs and pharmaceuticals is quite important because of their use not only as health care products but
More informationACD/Labs Software Impurity Resolution Management. Presented by Peter Russell
ACD/Labs Software Impurity Resolution Management Presented by Peter Russell Impurity Resolution Process Chemists Method Development Specialists Toxicology Groups Stability Groups Analytical Chemists 7/8/2016
More informationFall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers)
Suggested Reading: Fall Organic Chemistry Experiment #6 Fractional Crystallization (Resolution of Enantiomers) Jones Section 4.9 Physical Properties of Diastereomers: Optical Resolution pages 176-178 Introduction
More informationPerseverance. Experimentation. Knowledge.
2410 Intuition. Perseverance. Experimentation. Knowledge. All are critical elements of the formula leading to breakthroughs in chemical development. Today s process chemists face increasing pressure to
More informationA Novel Software Tool for Crystallization Process Development
A Novel Software Tool for Crystallization Process Development Christianto Wibowo *, Ketan D. Samant, Joseph W. Schroer, and Lionel O Young ClearWaterBay Technology, Inc. 20311 Valley Blvd. Suite C, Walnut,
More informationDesign of Experiments Helps Increase Yield of Pharmaceutical Intermediate from 70% to 88%
Design of Experiments Helps Increase Yield of Pharmaceutical Intermediate from 70% to 88% Researchers at Codexis Laboratories Singapore performed a full-factorial designed experiment with 20 runs to determine
More informationIntelligent NMR productivity tools
Intelligent NMR productivity tools Till Kühn VP Applications Development Pittsburgh April 2016 Innovation with Integrity A week in the life of Brian Brian Works in a hypothetical pharma company / university
More informationChemistry Departmental Mission Statement: Communicating Plus - Chemistry: Requirements for a major in chemistry:
Chemistry Professors Colleen M. Byron (Chair); Dean A. Katahira; Associate Professor Joseph D. Scanlon; Assistant Professor Patrick H. Willoughby; Stockroom Supervisor Barbara Johnson Departmental Mission
More informationMulti-Channel SFC System for Fast Chiral Method Development and Optimization
Multi-Channel SFC System for Fast Chiral Method Development and ptimization Lakshmi Subbarao, Ziqiang Wang, Ph.D., and Rui Chen, Ph.D. Waters Corporation, Milford, USA APPLICATIN BENEFITS The Method Station
More informationChemists Do you have the Bayer Spirit?
www.mybayerjob.de Chemists Do you have the Bayer Spirit? Research and Development, Synthesis, Analytics, In-house Consulting, Patents, Information Technology, Production, Marketing Chemists in Bayer s
More informationPeptide Isolation Using the Prep 150 LC System
Jo-Ann M. Jablonski and Andrew J. Aubin Waters Corporation, Milford, MA, USA APPLICATION BENEFITS The Prep 150 LC System, an affordable, highly reliable system for preparative chromatography, is suitable
More informationS ui t e 2, Gr ound F l oor, T ower B usi ness Cent r e, T ower S t r eet, S wat ar B K R Mal t a T. ( ) / 5 E.
S ui t e 2, Gr ound F l oor, T ower B usi ness Cent r e, T ower S t r eet, S wat ar B K R 4 0 1 3 - Mal t a T. ( + 3 5 6 ) 2 1 2 3 2 2 2 4 / 5 E. j obs@ v acancy cent r e. com V A CA NCY CE NT R E. COM
More informationTo satisfy us that the new active constituent meets the safety statutory criteria, applicants may provide any of the following, either singly or in co
Approval of a new active constituent 1. Satisfying the safety criteria for a new active constituent 2. Data list 3. Template for the dossier to support the approval of a new active constituent The Agvet
More informationPART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS.
PART II VIII. CONCERNING CHEMICAL. PHARMACEUTICAL AND BIOLOGICAL DOCUMENTATION FOR RADIOPHARMACEUTICAL PRODUCTS. The principle of GMP and the detailed guidelines are applicable to all operations which
More informationCHEM4. General Certificate of Education Advanced Level Examination January Unit 4 Kinetics, Equilibria and Organic Chemistry
Centre Number Surname Candidate Number For Examiner s Use Other Names Candidate Signature Examiner s Initials General Certificate of Education Advanced Level Examination January 2011 Question 1 2 Mark
More informationGreen Chemistry & Engineering for Pharmacuetical Industry Impact of Process Research / Route Scouting towards the Environment during API Life Cycle
Green Chemistry & Engineering for Pharmacuetical Industry Impact of Process Research / Route Scouting towards the Environment during API Life Cycle Dhileep Krishnamurthy, Ph.D. Outline Introduction Green
More informationGyula Körtvélyessy, PhD
Home-Office: Bimbó út 3O, Budapest Hungary H-1O22 Phone: (36)-1-316-541O Fax: (36)-1-336-0005 Mobil: (36)-20-344-0187 mailto:k.gyula@chello.hu http://members.chello.hu/k.gyula Gyula Körtvélyessy, PhD PERSONAL
More informationIDENTIFICATION AND QUANTITATION OF HARD-TO-RESOLVE INDIVIDUAL COMPONENTS IN MIXTURES WITHOUT CHROMATOGRAPHY, CHEMOMETRICS, AND REFERENCE STANDARDS
WHITE PAPER IDENTIFICATION AND QUANTITATION OF HARD-TO-RESOLVE INDIVIDUAL COMPONENTS IN MIXTURES WITHOUT CHROMATOGRAPHY, CHEMOMETRICS, AND REFERENCE STANDARDS Aleksandr V. Mikhonin, Matthew T. Muckle,
More informationSeparation of Chiral Pesticides by SFC and HPLC
Separation of Chiral Pesticides by SFC and HPLC Tong Zhang (1), Pilar Franco (1), Joseph Barendt (2) (1) Chiral Technologies Europe (Illkirch, France) (2) Chiral Technologies, Inc (PA 19380 USA) 1 Chirality
More informationSimplified Approaches to Impurity Identification using Accurate Mass UPLC/MS
Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS Marian Twohig, Michael D. Jones, Dominic Moore, Peter Lee, and Robert Plumb Waters Corporation, Milford, MA, USA APPLICATION
More informationCOMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE
NUE FEATURE T R A N S F O R M I N G C H A L L E N G E S I N T O M E D I C I N E Nuevolution Feature no. 1 October 2015 Technical Information COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE A PROMISING
More informationSPEED AND ACCURACY TO DRUG DEVELOPMENT
HOW qnmr BRINGS SPEED ND CCURCY TO DRUG DEVELOPMENT INTRODUCTION The total cost of bringing a drug to market is now estimated at about $2.5 billion 1, and the pressure to advance new drugs faster is greater
More information10/18/2006. Biotage A Life Science Technology Company
10/18/2006 Biotage A Life Science Technology Company About Biotage Headquartered in Uppsala, Sweden Three Centers of Excellence Uppsala, Sweden Research & Development Charlottesville VA, U.S.A. Instrument
More informationThe Comprehensive Report
High-Throughput Screening 2002: New Strategies and Technologies The Comprehensive Report Presented by HighTech Business Decisions 346 Rheem Blvd., Suite 208, Moraga, CA 94556 Tel: (925) 631-0920 Fax: (925)
More informationTHE WORLD S FASTEST MOST PRECISE FORECASTS
Ed Keible Executive Chairman Cornelius, NC 28031 Ed@tempoquest.com 650 224 0296 www.tempoquest.com Gene Pache Chief Operating Officer Omaha, NE 68144 Gene@tempoquest.com 402 578 1722 www.tempoquest.com
More informationLC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note
LC walk-up system using the Agilent 12 Series LC Method Development Solution and Agilent Easy Access software Test of reaction kinetics, column scouting, and impurity checks with one LC system and up to
More informationChemists are from Mars, Biologists from Venus. Originally published 7th November 2006
Chemists are from Mars, Biologists from Venus Originally published 7th November 2006 Chemists are from Mars, Biologists from Venus Andrew Lemon and Ted Hawkins, The Edge Software Consultancy Ltd Abstract
More informationComputational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007
Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based
More informationChiroSolv EnantioPrep Kits Deliver Pure Enantiomers
ChiroSolve Inc. 616 Stendhal Ln., Cupertino, CA 95014, USA Telephone: (408) 834-8597; Fax: (408) 351-7900 Website: http://www.chirosolve.com Technical/Customer Support: info@chirosolve.com Sales support:
More informationIdentification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate
Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate Michael D. Jones, Xiang Jin Song, Robert S. Plumb, Peter J. Lee, and
More informationInstitute of Isotopes Co., Ltd.
Carbon-14 Labelled PESTICIDES Institute of Isotopes Co., Ltd. Konkoly Thege M. u. 29-33., Budapest, 1121 HUNGARY Tel.: +36 1 392 2577, +36 1 395 9081 Fax: +36 1 395 9247, +36 1 392 2575 commerce@izotop.hu
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
European Medicines Agency Veterinary Medicines and Inspections COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON THE CHEMISTRY OF NEW ACTIVE SUBSTANCES DISCUSSION IN THE QUALITY WORKING
More informationKalexsyn Overview Kalexsyn, Inc Campus Drive Kalamazoo, MI Phone: (269) Fax: (269)
Kalexsyn verview 2018 Kalexsyn, Inc. 4502 Campus Drive Kalamazoo, MI 49008 Phone: (269) 488-8488 Fax: (269) 488-8490 info@kalexsyn.com What we do Custom synthesis of difficult molecules, including heterocycles,
More informationCHEMISTRY (CHE) CHE 104 General Descriptive Chemistry II 3
Chemistry (CHE) 1 CHEMISTRY (CHE) CHE 101 Introductory Chemistry 3 Survey of fundamentals of measurement, molecular structure, reactivity, and organic chemistry; applications to textiles, environmental,
More informationThe shortest path to chemistry data and literature
R&D SOLUTIONS Reaxys Fact Sheet The shortest path to chemistry data and literature Designed to support the full range of chemistry research, including pharmaceutical development, environmental health &
More informationt Making Pharma Greener:
ACS Green Chemistry Institute t Making Pharma Greener: 5Years of the ACS GCI Pharmaceutical Roundtable Buzz Cue ACS Green Chemistry Institute Governing Board 1155 Sixteenth Street, NW, Washington, DC 20036
More informationProcess Development & Scale-Up of the AIR Technology
Process Development & Scale-Up of the AIR Technology Lloyd Johnston, Ph.D. Vice President of Process Development & Manufacturing October 6, 2005 Pharmaceutical Industry o Delivering needed therapeutics
More informationPharmaceutical applications of Jacobsen HKR technology
Pharmaceutical applications of Jacobsen HKR technology Recent advances in Hydrolytic Kinetic Resolution (HKR) technology have extended its potential application in pharmaceutical syntheses. Dr Marcello
More informationOptiform Technologies A Fit-for-Purpose Solution to Solid-State Issues
Optiform Technologies A Fit-for-Purpose Solution to Solid-State Issues Dr. David Igo Director, Optiform Technologies Catalent Pharma Solutions AAPS 2010, New Orleans, LA November 15-17, 2010 Optiform Technologies
More informationFRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )
FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC ) SARomics Biostructures AB & Red Glead Discovery AB Medicon Village, Lund, Sweden Fragment-based lead discovery The basic idea:
More informationFRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Design of screening projects General remarks Introduction Screening is done to identify new chemical substances against molecular mechanisms of a disease It is a question of
More informationMass Spectrometry. Quantitative Mass Spectrometry Chiral Mass Spectrometry
Mass Spectrometry Quantitative Mass Spectrometry Chiral Mass Spectrometry Quantitation by MS Goal is to develop methodology to sensitively, specifically, accurately and rapidly measure one or more compounds
More informationReaxys Improved synthetic planning with Reaxys
R&D SOLUTIONS Reaxys Improved synthetic planning with Reaxys Integration of custom inventory and supplier catalogs in Reaxys helps chemists overcome challenges in planning chemical synthesis due to the
More informationUsing Design of Experiments to Optimize Chiral Separation
1 of 7 10/5/2010 1:15 PM Home About us Guidance e-newsletter Expert Insights Readers' Choice Resources Audio & Video» QbD News Categorized Expert Insights, Resources Using Design of Experiments to Optimize
More informationHighly automated protein formulation development: a case study
Application Note Highly automated protein formulation development: a case study Introduction and background Therapeutic proteins can be inherently prone to degradation and instability, and they often pose
More informationProduktivitätswerkzeuge für die NMR
Produktivitätswerkzeuge für die NMR Till Kühn VP Applications Development Benutzertagung Karlsruhe November 2016 Innovation with Integrity A week in the life of Brian Brian Works in a hypothetical pharma
More informationIntroduction to E&Ls 1
Introduction to E&Ls 1 Overview What industries need to determine E&Ls Define extractables and leachables Basic overview of an E&L study Regulatory landscape 2 A leader in plastics analysis Jordi Labs
More informationHead of the Certification of Substances Division, EDQM
Hélène BRUGUERA Head of the Certification of Substances Division, EDQM The views expressed in this presentation are my own views and do not necessarily represent official policy More and more manufacturers
More informationNaturalFacts. Introducing our team. New product announcements, specials and information from New Roots Herbal. April 2009
NaturalFacts New product announcements, specials and information from New Roots Herbal April 2009 Introducing our team Introducing Our Science Team Dr. ABZAL HOSSAIN Ph.D. Analytical Chemistry Dr. Hossain
More informationSupporting Information for: Using a Lipase as a High Throughput Screening Method for Measuring the Enantiomeric. Excess of Allylic Acetates
Supporting Information for: Using a Lipase as a High Throughput Screening Method for Measuring the Enantiomeric Excess of Allylic Acetates M. Burak Onaran and Christopher T. Seto* Department of Chemistry,
More informationKALAMAZOO COLLEGE ACADEMIC CATALOG
KALAMAZOO COLLEGE 2018-2019 ACADEMIC CATALOG Chemistry Professors: Bartz (Chair W, S), Frantz, Furchak, Furge, Slough, T. Smith, Stevens-Truss (Chair), Williams The chemistry program stresses the art of
More informationFragment-based drug discovery
Fragment-based drug discovery Dr. Till Kühn VP Applications Development MRS, Bruker BioSpion User s meeting, Brussels, November 2016 Innovation with Integrity The principle of Fragment Based Screening
More informationIn Silico Investigation of Off-Target Effects
PHARMA & LIFE SCIENCES WHITEPAPER In Silico Investigation of Off-Target Effects STREAMLINING IN SILICO PROFILING In silico techniques require exhaustive data and sophisticated, well-structured informatics
More informationServices in Chemistry for a Sustainable World
Table of Content 2 Services in Chemistry for a Sustainable World COMPANY PROFILE TECHNICAL PROFILE General Information... 3 Our Services... 4 Project Types & Pricing Options... 5 Reaction & Catalyst Portfolio...
More informationNMR Solutions for drug discovery
NMR Solutions for drug discovery Dr. Matteo Pennestri London, UK Bruker Users Meeting Innovation with Integrity The principle of Fragment Based Screening from efficient fragments to Drug candidates Fragment
More informationUniversity of Groningen
University of Groningen Dutch Resolution, A New Technology in Classical Resolution Broxterman, Quirinus B.; Echten, Erik van; Hulshof, Lumbertus A.; Kaptein, Bernard; Kellogg, Richard M.; Minnaard, Adriaan;
More informationReferences. Continuous Manufacturing Process Development Plant Realizations. Microinnova Engineering GmbH. Europapark Allerheiligen bei Wildon
References Continuous Manufacturing Process Development Plant Realizations Microinnova Engineering GmbH Europapark 1 8412 Allerheiligen bei Wildon T +43 (0) 3182 62626-0 office@microinnova.com www.microinnova.com
More informationThe Comprehensive Report
The Comprehensive Report Presented by HighTech Business Decisions 346 Rheem Blvd., Suite 208, Moraga, CA 94556 Tel: (925) 631-0920 Fax: (925) 631-0972 www.hightechdecisions.com October 2005 FORWARD AND
More informationCheminformatics Role in Pharmaceutical Industry. Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS
Cheminformatics Role in Pharmaceutical Industry Randal Chen Ph.D. Abbott Laboratories Aug. 23, 2004 ACS Agenda The big picture for pharmaceutical industry Current technological/scientific issues Types
More informationDesigned polymers for purification of flavor oils
Designed polymers for purification of flavor oils IFEAT Conference 2014 Rome, September 23, 2014 Ecevit Yilmaz, PhD Global Product Manager Industrial Resins MIP Technologies AB a subsidiary of Biotage
More informationSolution Story: Dr. Carsten Schauerte, Managing Director of solid-chem GmbH
Reaxys CHEMICAL R&D Solution Story: Dr. Carsten Schauerte, Managing Director of solid-chem GmbH Reaxys meets the property data needs for effective analytics, saving time and advancing scientific work Summary
More informationPrinciples of Gas- Chromatography (GC)
Principles of Gas- Chromatography (GC) Mohammed N. Sabir January 2017 10-Jan-17 1 GC is a chromatographic technique utilizes gas as the mobile phase which is usually an inert gas (Hydrogen, Helium, Nitrogen
More informationPharma and Suppliers: Collaborating on Green Chemistry. Launch of PMI tool. ACS Green Chemistry Institute Pharmaceutical Roundtable
Pharma and Suppliers: Collaborating on Green Chemistry. Launch of PMI tool ACS Green Chemistry Institute Pharmaceutical Roundtable Dave Hughes 08-Feb-2011 2011 Copyright American Chemical Society Green
More informationAbstract Process Economics Program Report 232 CHIRAL INTERMEDIATES (March 2001)
Abstract Process Economics Program Report 232 CHIRAL INTERMEDIATES (March 2001) Chiral chemicals are a unique class of compounds that, although chemically identical, exist as mirror images of each other
More informationEarly Stages of Drug Discovery in the Pharmaceutical Industry
Early Stages of Drug Discovery in the Pharmaceutical Industry Daniel Seeliger / Jan Kriegl, Discovery Research, Boehringer Ingelheim September 29, 2016 Historical Drug Discovery From Accidential Discovery
More informationGood Read-Across Practice 1: State of the Art of Read-Across for Toxicity Prediction. Mark Cronin Liverpool John Moores University England
Good Read-Across Practice 1: State of the Art of Read-Across for Toxicity Prediction Mark Cronin Liverpool John Moores University England Acknowledgement What I am Going to Say Background and context State
More informationDavid Ford, Ph.D. Mettler Toledo Autochem Symposium June 21, 2017 Cambridge, MA
David Ford, Ph.D. Mettler Toledo Autochem Symposium June 21, 2017 Cambridge, MA Snapdragon Chemistry Snapdragon Chemistry was created to deliver complete flow chemistry solutions to clients. Using advanced
More informationBasic Principles for Purification Using Supercritical Fluid Chromatography
Basic Principles for Purification Using Supercritical Fluid Chromatography Jo-Ann M. Jablonski, Christopher J. Hudalla, Kenneth J. Fountain, Steven M. Collier, and Damian Morrison Waters Corporation, Milford,
More informationASAP concept and case studies
ASAP concept and case studies Sabine Thielges Stability Testing for Pharmaceuticals 20-21 March 2013 Background: Traditional Approaches to Stability Studies (ICH) 1. Long-term e.g. 25 C/60%RH, 30 C/75%RH
More informationSCI Career Options Seminar My Career in the Pharmaceutical Industry. Gareth Ensor, AstraZeneca University of York 14 th November 2012
SCI Career Options Seminar My Career in the Pharmaceutical Industry Gareth Ensor, AstraZeneca University of York 14 th November 2012 Gareth Ensor Career Profile Graduated with MChem Chemistry (2:1) from
More informationAnalysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass Frontier TM
Application Note: 320 Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass Frontier TM Key Words Metabolism Study Structure Elucidation Metabolite ID Mass Frontier Chromatography
More informationUsing Forecast Errors for Business Optimisation
Using Forecast Errors for Business Optimisation A guide for Project Managers David Evans BEng (Hons), GDipAppFin (Finsia) [e] evansd246@gmail.com Disclaimer This publication contains general information
More informationCOPYRIGHTED MATERIAL. Introduction
1 Introduction We tend to think that what we usually do is appropriate. This is often true in our daily life. However, it is not necessarily true in the field of science. For example, we usually run reactions
More informationQuality by Design and Analytical Methods
Quality by Design and Analytical Methods Isranalytica 2012 Tel Aviv, Israel 25 January 2012 Christine M. V. Moore, Ph.D. Acting Director ONDQA/CDER/FDA 1 Outline Introduction to Quality by Design (QbD)
More informationA Fast and Sensitive Method for Residual Hydrazine Analysis in Pharmaceutical Samples
A Fast and Sensitive Method for Residual Hydrazine Analysis in Pharmaceutical Samples Vera Leshchinskaya, Priscilla Richberg, Yury Zelechonok*, and Anne Kelly Bristol Myers Squibb Company, P.O.BOX 4000,
More informationFACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques
M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques Code No. 6001 / S 1 a) Describe the instrumentation and applications of UV-visible
More informationPosterREPRINT AN INTERACTIVE PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE FOR EARLY CANDIDATE ANALYSIS IN DRUG DISCOVERY INTRODUCTION
INTRODUCTION Full characterization of the physicochemical properties of new chemical entities (NCE s) typically takes place in pharmaceutical development laboratories. However, in an effort to minimize
More informationIntroduction... vii ACC Economics and Statistics Department Staff... vii 1. CHEMISTRY AND THE ECONOMY...1
TABLE OF CONTENTS Introduction... vii ACC Economics and Statistics Department Staff... vii 1. CHEMISTRY AND THE ECONOMY...1 Chemistry in Our Lives...2 Economic Contributions of the Business of Chemistry...4
More informationFACULTY OF PHARMACY. M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques
M. Pharmacy I Semester (Suppl.) Examination, November 2015 (Common To All) Subject: Pharmaceutical Analytical Techniques Code No. 6001 / S Note: Answer any Five questions. All questions carry equal marks.
More information